Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa.

Strayer DR, Carter WA, Stouch BC, Stittelaar KJ, Thoolen RJ, Osterhaus AD, Mitchell WM.

Antiviral Res. 2014 Oct;110:175-80. doi: 10.1016/j.antiviral.2014.07.010. Epub 2014 Aug 9.

PMID:
25111905
2.

Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.

Wonderlich ER, Swan ZD, Bissel SJ, Hartman AL, Carney JP, O'Malley KJ, Obadan AO, Santos J, Walker R, Sturgeon TJ, Frye LJ Jr, Maiello P, Scanga CA, Bowling JD, Bouwer AL, Duangkhae PA, Wiley CA, Flynn JL, Wang J, Cole KS, Perez DR, Reed DS, Barratt-Boyes SM.

J Immunol. 2017 Feb 15;198(4):1616-1626. doi: 10.4049/jimmunol.1601770. Epub 2017 Jan 6.

3.

Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.

Kitano M, Itoh Y, Ishigaki H, Nakayama M, Ishida H, Pham VL, Arikata M, Shichinohe S, Tsuchiya H, Kitagawa N, Kobayashi M, Yoshida R, Sato A, Le QM, Kawaoka Y, Ogasawara K.

Antimicrob Agents Chemother. 2014 Aug;58(8):4795-803. doi: 10.1128/AAC.02817-14. Epub 2014 Jun 9.

4.

Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques.

Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, van Amerongen G, Linster M, Zaaraoui F, van Ijcken WF, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Andeweg AC, Kuiken T.

Vet Pathol. 2010 Nov;47(6):1040-7. doi: 10.1177/0300985810374836. Epub 2010 Jul 20.

PMID:
20647595
5.

Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Van Hoeven N, Belser JA, Szretter KJ, Zeng H, Staeheli P, Swayne DE, Katz JM, Tumpey TM.

J Virol. 2009 Apr;83(7):2851-61. doi: 10.1128/JVI.02174-08. Epub 2009 Jan 14.

6.

Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Muramoto Y, Shoemaker JE, Le MQ, Itoh Y, Tamura D, Sakai-Tagawa Y, Imai H, Uraki R, Takano R, Kawakami E, Ito M, Okamoto K, Ishigaki H, Mimuro H, Sasakawa C, Matsuoka Y, Noda T, Fukuyama S, Ogasawara K, Kitano H, Kawaoka Y.

J Virol. 2014 Aug;88(16):8981-97. doi: 10.1128/JVI.00907-14. Epub 2014 Jun 4.

7.

Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.

Nakayama M, Shichinohe S, Itoh Y, Ishigaki H, Kitano M, Arikata M, Pham VL, Ishida H, Kitagawa N, Okamatsu M, Sakoda Y, Ichikawa T, Tsuchiya H, Nakamura S, Le QM, Ito M, Kawaoka Y, Kida H, Ogasawara K.

PLoS One. 2013 Dec 23;8(12):e82740. doi: 10.1371/journal.pone.0082740. eCollection 2013.

8.

A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.

Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.

Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3.

PMID:
18164788
9.

Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).

Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD.

Vet Pathol. 2003 May;40(3):304-10.

PMID:
12724572
10.

Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses.

Lipatov AS, Kwon YK, Sarmento LV, Lager KM, Spackman E, Suarez DL, Swayne DE.

PLoS Pathog. 2008 Jul 11;4(7):e1000102. doi: 10.1371/journal.ppat.1000102.

11.

Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Szretter KJ, Gangappa S, Belser JA, Zeng H, Chen H, Matsuoka Y, Sambhara S, Swayne DE, Tumpey TM, Katz JM.

J Virol. 2009 Jun;83(11):5825-34. doi: 10.1128/JVI.02144-08. Epub 2009 Mar 18.

12.

Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells.

Chan MC, Chan RW, Yu WC, Ho CC, Chui WH, Lo CK, Yuen KM, Guan YI, Nicholls JM, Peiris JS.

Respir Res. 2009 Oct 30;10:102. doi: 10.1186/1465-9921-10-102.

13.

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2009 Feb 1;199(3):405-13. doi: 10.1086/595984.

PMID:
19061423
14.

Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

Sawai T, Itoh Y, Ozaki H, Isoda N, Okamoto K, Kashima Y, Kawaoka Y, Takeuchi Y, Kida H, Ogasawara K.

Immunology. 2008 Jun;124(2):155-65. doi: 10.1111/j.1365-2567.2007.02745.x. Epub 2008 Jan 16.

15.

H5N1 Virus Attachment to Lower Respiratory Tract.

van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T.

Science. 2006 Apr 21;312(5772):399. Epub 2006 Mar 23.

16.

A primate model to study the pathogenesis of influenza A (H5N1) virus infection.

Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD.

Avian Dis. 2003;47(3 Suppl):931-3.

PMID:
14575089
17.

Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates.

Soloff AC, Bissel SJ, Junecko BF, Giles BM, Reinhart TA, Ross TM, Barratt-Boyes SM.

J Infect Dis. 2014 Jun 15;209(12):2012-6. doi: 10.1093/infdis/jiu009. Epub 2014 Jan 7.

18.

Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus.

Tolnay AE, Baskin CR, Tumpey TM, Sabourin PJ, Sabourin CL, Long JP, Pyles JA, Albrecht RA, García-Sastre A, Katze MG, Bielefeldt-Ohmann H.

Arch Virol. 2010 Jun;155(6):905-14. doi: 10.1007/s00705-010-0662-8. Epub 2010 Apr 7.

19.

Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells.

Matthaei M, Budt M, Wolff T.

PLoS One. 2013;8(2):e56659. doi: 10.1371/journal.pone.0056659. Epub 2013 Feb 25.

20.

[Investigation of therapeutic and protective effect of Reaferon-ES Lipint on mice infected with avian influenza virus (subtype H5N1)].

Demina OK, Sergeev AA, Agafonov AP, Shikov AN, Sementsova AO, Sergeev AA, Sergeev AN, Drozdov IG.

Antibiot Khimioter. 2009;54(9-10):27-9. Russian.

PMID:
20415260

Supplemental Content

Support Center